L-발린

ACE inhibitory casein peptide lowers blood pressure and reshapes gut microbiota in a randomized double blind placebo controlled trial.

1. Sci Rep. 2025 Apr 22;15(1):13840. doi: 10.1038/s41598-025-98446-6. ACE inhibitory casein peptide lowers blood pressure and reshapes gut microbiota in a randomized double blind placebo controlled trial. Li K(1), Jiang P(2), Li S(3), Sun J(1), Qi C(4). Author information: (1)Institute of Nutrit

Dietary Lipid Quantity and Quality Modulate the Postprandial Metabolomic Profile in Patients with Metabolic Syndrome.

2. Nutrients. 2024 Dec 11;16(24):4267. doi: 10.3390/nu16244267. Dietary Lipid Quantity and Quality Modulate the Postprandial Metabolomic Profile in Patients with Metabolic Syndrome. Mora-Ortiz M(1)(2)(3)(4), Yubero-Serrano EM(1)(2)(3)(4)(5), Priego-Capote F(6)(7), Gutierrez-Mariscal FM(1)(2)(3)(

Postprandial Glucose and Gastrointestinal Hormone Responses of Healthy Subjects to Wheat Biscuits Enriched with L-Arginine or Branched-Chain Amino Acids of Plant Origin.

3. Nutrients. 2022 Oct 19;14(20):4381. doi: 10.3390/nu14204381. Postprandial Glucose and Gastrointestinal Hormone Responses of Healthy Subjects to Wheat Biscuits Enriched with L-Arginine or Branched-Chain Amino Acids of Plant Origin. Yanni AE(1), Kokkinos A(2), Binou P(1), Papaioannou V(3), Hala

The Consequence of Drug-Drug Interactions Influencing the Interplay between P-Glycoprotein and Cytochrome P450 3a: An Ex Vivo Study with Rat Precision-Cut Intestinal Slices.

4. Drug Metab Dispos. 2016 May;44(5):683-91. doi: 10.1124/dmd.115.068684. Epub 2016 Mar 1. The Consequence of Drug-Drug Interactions Influencing the Interplay between P-Glycoprotein and Cytochrome P450 3a: An Ex Vivo Study with Rat Precision-Cut Intestinal Slices. Li M(1), de Graaf IA(2), Siiss

Evaluation of vancomycin-based synergistic system with amino acid ester chiral ionic liquids as additives for enantioseparation of non-steroidal anti-inflammatory drugs by capillary electrophoresis.

5. Talanta. 2014 Feb;119:193-201. doi: 10.1016/j.talanta.2013.10.042. Epub 2013 Nov 11. Evaluation of vancomycin-based synergistic system with amino acid ester chiral ionic liquids as additives for enantioseparation of non-steroidal anti-inflammatory drugs by capillary electrophoresis. Zhang J(

Synergistic effects of sour taste and low temperature in suppressing the bitterness of Aminoleban® EN.

6. Chem Pharm Bull (Tokyo). 2011;59(5):536-40. doi: 10.1248/cpb.59.536. Synergistic effects of sour taste and low temperature in suppressing the bitterness of Aminoleban® EN. Haraguchi T(1), Yoshida M, Hazekawa M, Uchida T. Author information: (1)School of Pharmaceutical Sciences, Mukogawa Women

Combination of the dipeptidyl peptidase IV inhibitor LAF237 [(S)-1-[(3-hydroxy-1-adamantyl)ammo]acetyl-2-cyanopyrrolidine] with the angiotensin II type 1 receptor antagonist valsartan [N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl]-L-valine] enhances pancreatic islet morphology and function in a mouse model of type 2 diabetes.

7. J Pharmacol Exp Ther. 2008 Dec;327(3):683-91. doi: 10.1124/jpet.108.142703. Epub 2008 Sep 11. Combination of the dipeptidyl peptidase IV inhibitor LAF237 [(S)-1-[(3-hydroxy-1-adamantyl)ammo]acetyl-2-cyanopyrrolidine] with the angiotensin II type 1 receptor antagonist valsartan [N-(1-oxopenty

The effect of cysteine analogues on the excretion of urinary sulphate in the rat following cysteine administration.

8. Drug Metabol Drug Interact. 2004;20(1-2):1-10. doi: 10.1515/dmdi.2004.20.1-2.1. The effect of cysteine analogues on the excretion of urinary sulphate in the rat following cysteine administration. Roopnarinsingh ES(1), Steventon GB, Harris RM, Waring RH, Mitchell SC. Author information: (1)Sec

L-tyrosine potentiation of opioid-induced analgesia utilizing the hot-plate test.

9. J Pharmacol Exp Ther. 1994 Jun;269(3):1190-5. L-tyrosine potentiation of opioid-induced analgesia utilizing the hot-plate test. Hull KM(1), Tolland DE, Maher TJ. Author information: (1)Department of Pharmacology, Massachusetts College of Pharmacy, Boston. The effects of L-tyrosine (L-TYR) on

L-tyrosine fails to potentiate several peripheral actions of the sympathomimetics.

10. Pharmacol Biochem Behav. 1991 Jul;39(3):755-9. doi: 10.1016/0091-3057(91)90159-y. L-tyrosine fails to potentiate several peripheral actions of the sympathomimetics. Hull KM(1), Maher TJ. Author information: (1)Department of Pharmacology, Massachusetts College of Pharmacy, Boston 02115. We

L-tyrosine potentiates the anorexia induced by mixed-acting sympathomimetic drugs in hyperphagic rats.

11. J Pharmacol Exp Ther. 1990 Nov;255(2):403-9. L-tyrosine potentiates the anorexia induced by mixed-acting sympathomimetic drugs in hyperphagic rats. Hull KM(1), Maher TJ. Author information: (1)Department of Pharmacology, Massachusetts College of Pharmacy and Allied Health Sciences, Boston.

O2 metabolites and neutrophil elastase synergistically cause edematous injury in isolated rat lungs.

12. J Appl Physiol (1985). 1986 Dec;61(6):2224-9. doi: 10.1152/jappl.1986.61.6.2224. O2 metabolites and neutrophil elastase synergistically cause edematous injury in isolated rat lungs. Baird BR, Cheronis JC, Sandhaus RA, Berger EM, White CW, Repine JE. Addition of glucose oxidase (GO) increased

Potentiation by sulfide of hydrogen peroxide-induced killing of Escherichia coli.

13. Infect Immun. 1985 Sep;49(3):538-43. doi: 10.1128/iai.49.3.538-543.1985. Potentiation by sulfide of hydrogen peroxide-induced killing of Escherichia coli. Berglin EH, Carlsson J. L-Cysteine potentiates 100-fold the hydrogen peroxide-induced killing of a growing culture of Escherichia coli K

The Impact of Amino Acids on Postprandial Glucose and Insulin Kinetics in Humans: A Quantitative Overview.

14. Nutrients. 2020 Oct 21;12(10):3211. doi: 10.3390/nu12103211. The Impact of Amino Acids on Postprandial Glucose and Insulin Kinetics in Humans: A Quantitative Overview. Sloun BV(1)(2), Goossens GH(1)(3), Erdos B(1)(2), Lenz M(4)(5), Riel NV(6), Arts ICW(1)(2)(7). Author information: (1)TiFN,

WITHDRAWN: Amino acids for amyotrophic lateral sclerosis / motor neuron disease.

15. Cochrane Database Syst Rev. 2008 Apr 16;(2):CD003457. doi: 10.1002/14651858.CD003457.pub2. WITHDRAWN: Amino acids for amyotrophic lateral sclerosis / motor neuron disease. Parton M(1), Mitsumoto H, Leigh PN. Author information: (1)National Hospital for Neurology and Neurosurgery, Centre for

Amino acids for amyotrophic lateral sclerosis / motor neuron disease.

19. Cochrane Database Syst Rev. 2003;(4):CD003457. doi: 10.1002/14651858.CD003457. Amino acids for amyotrophic lateral sclerosis / motor neuron disease. Parton M(1), Mitsumoto H, Leigh PN. Author information: (1)Department of Neurology, Guy's, King's and St. Thomas's School of Medicine and The I